snris
Treatment for Depersonalization-derealization disorder (DPDR)
SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors) modulate neurotransmitter activity by blocking the reuptake of serotonin and norepinephrine, potentially alleviating DPDR symptoms through enhanced synaptic neurotransmitter availability. By increasing neural signaling in key brain regions associated with emotional processing and perception, SNRIs may help reduce the dissociative experiences characteristic of DPDR and improve overall cognitive-emotional regulation.